Company Overview and News


Add GNMK
to your dashboard

Headline News

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GenMark Diagnostics, Inc. (GNMK)

2017-11-07 accesswire
NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GenMark Diagnostics, Inc. ("GenMark" or the "Company") (NASDAQ: GNMK). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/gnmk.

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst

2017-11-06 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (692-3)

10 Cheap Stocks to Buy With Only $12 | InvestorPlace

2017-11-01 investorplace
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all offer impressive value for money and big upside potential. (84-1)

Shipping Stock Performance Review -- Capital Product Partners, Star Bulk Carriers, Overseas Shipholding, and Frontline

2017-09-25 prnewswire
If you want a Stock Review on CPLP, SBLK, OSG, or FRO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. For today, DailyStockTracker.com has issued research reports on four Shipping companies, particularly, Capital Product Partners L.P. (NASDAQ: CPLP), Star Bulk Carriers Corp. (NASDAQ: SBLK), Overseas Shipholding Group Inc. (NYSE: OSG), and Frontline Ltd (NYSE: FRO). (53-0)

Today's Research Report Coverage on Medical Equipment Stocks -- AcelRx Pharma, GenMark Diagnostics, ViewRay, and Nevro

2017-09-25 prnewswire
If you want a Stock Review on ACRX, GNMK, VRAY, or NVRO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today, DailyStockTracker.com focuses on the Medical Appliances and Equipment industry, which primarily offers equipment and devices that are designed for diagnosis, monitoring, and treatment of patients in healthcare systems worldwide. This equipment ranges greatly in complexity and function. (92-1)

GenMark Is Set To Surge

2017-09-18 seekingalpha
The FDA clearance of its respiratory panel on its ePlex system will boost earnings in the coming quarters.

Will Teladoc (TDOC) Pull Off a Surprise in Q2 Earnings?

2017-07-31 zacks
Teladoc Inc. (TDOC - Free Report) is scheduled to report second-quarter 2017 results on Aug 2, after market close.

The Top 100 Developers of In-Vitro Diagnostics Tests for Infectious Diseases

2017-07-14 prnewswire
- Beijing Wantai Biological Pharmacy's Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China. (0-2)

The Top 200 Developers of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases

2017-07-14 prnewswire
NEW YORK, July 13, 2017 /PRNewswire/ -- Did you know? - Lewis Stuart is Vice President, Sales & Marketing, U.S. Breast/Colon at Genomic Health, Inc.. - Beijing Wantai Biological Pharmacy's Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China. - MDxHealth was the winner of the 2016 Frost & Sullivan Global Prostate Cancer Diagnostics Technology Innovation Award.

The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases

2017-07-14 prnewswire
NEW YORK, July 13, 2017 /PRNewswire/ -- Did you know? - Daniella Cramp is Global President, Cardiometabolic at Alere Inc.. - Beijing Wantai Biological Pharmacy's Beijing plant is the largest manufacturing base for the production of infectious diseases diagnostics in China. - MDxHealth was the winner of the 2016 Frost & Sullivan Global Prostate Cancer Diagnostics Technology Innovation Award. - iTP Biomedica Corp.

GenMark Diagnostics Achieves CE Mark For Its Eplex Blood Culture Identification Gram-Positive And Gram-Negative Panels

2017-06-30 devicespace
CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In-Vitro Diagnostic Devices Directive (98/79/EC) for its ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel and its Blood Culture Identification Gram-Negative (BCID-GN) Panel.

PacBio Not Back To Square One But Definitely Back To A 'Show Me' Story

2017-06-22 seekingalpha
PacBio has been hammered by slower adoption of its new Sequel systems and Roche deciding to walk away from the clinical diagnostics partnership.

BRIEF-Genmark Diagnostics prices upsized public offering of common stock

2017-06-14 reuters
* Genmark Diagnostics Inc says priced offering of 6.4 million shares of its common stock at a public offering price of $11.75 per share Source text for Eikon: Further company coverage:

CUSIP: 372309104